Loading…
Reported covered position: Legislative Assistant, Legislative Correspondent, Staff Assistant, Intern, Rep. Patrick Tiberi
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Stop Corporate Takeovers of Physicians Act of 2026
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2026 · third_quarter · Q3
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.
Issues related to tariffs, trade, and U.S. trade policy.
Source: Senate LDA
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Ensuring Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.
Ensuring Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Ensuring Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act).
Ensuring Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine and issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025).
Protecting Patient Access to Cancer and Complex Therapies Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act).
Protecting Patient Access to Cancer and Complex Therapies Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine and issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025).
Hospital Inpatient Services Modernization Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine and issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025).
Home Health Stabilization Act of 2025
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine and issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025).
Home Health Stabilization Act of 2025
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act).
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act).
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine and issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025).
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, and DIR fees; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act; Appropriations report language requests in support of the Food As Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy; Tax Relief for American Families and Workers Act of 2024 (H.R.7024).
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts and provider reimbursement; Hospital Inpatient Services Modernization Act (H.R.8260); Telehealth Modernization Act of 2024 (H.R. 7623); Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act; Appropriations report language requests in support of the Food as Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy.
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act (H.R.8260); Telehealth Modernization Act of 2024 (H.R. 7623); Appropriations report language requests in support of the Food as Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act (H.R.8260); Telehealth Modernization Act of 2024 (H.R. 7623); Appropriations report language requests in support of the Food as Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts and provider reimbursement; Hospital Inpatient Services Modernization Act (H.R.8260); Telehealth Modernization Act of 2024 (H.R. 7623); Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act; Appropriations report language requests in support of the Food as Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, and DIR fees; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act; Appropriations report language requests in support of the Food As Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy; Tax Relief for American Families and Workers Act of 2024 (H.R.7024).
Preparing for All Hazards and Pathogens Reauthorization Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421); fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); provider reimbursement, workforce shortages, pandemic preparedness, and product shortages.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421): to reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes; fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); , provider relief, workforce shortages, pandemic preparedness, and product shortages
Fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); the National Defense Authorization Act (H.R. 8070); provider reimbursement, workforce shortages, pandemic preparedness, and product shortages.
Fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); the National Defense Authorization Act (H.R. 8070); provider reimbursement, workforce shortages, pandemic preparedness, and product shortages.
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421): to reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes; fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); , provider relief, workforce shortages, pandemic preparedness, and product shortages
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421); fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); provider reimbursement, workforce shortages, pandemic preparedness, and product shortages.
Tax Relief for American Families and Workers Act of 2024
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, and DIR fees; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act; Appropriations report language requests in support of the Food As Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy; Tax Relief for American Families and Workers Act of 2024 (H.R.7024).
Tax Relief for American Families and Workers Act of 2024
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Tax Relief for American Families and Workers Act of 2024 (H.R.7024)
Tax Relief for American Families and Workers Act of 2024
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Tax Relief for American Families and Workers Act of 2024 (H.R.7024); research and development tax credit.
Telehealth Modernization Act of 2024
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts and provider reimbursement; Hospital Inpatient Services Modernization Act (H.R.8260); Telehealth Modernization Act of 2024 (H.R. 7623); Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy
Telehealth Modernization Act of 2024
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act (H.R.8260); Telehealth Modernization Act of 2024 (H.R. 7623); Appropriations report language requests in support of the Food as Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy.
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); the National Defense Authorization Act (H.R. 8070); provider reimbursement, workforce shortages, pandemic preparedness, and product shortages.
Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); the National Defense Authorization Act (H.R. 8070); provider reimbursement, workforce shortages, pandemic preparedness, and product shortages.
Hospital Inpatient Services Modernization Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act (H.R.8260); Telehealth Modernization Act of 2024 (H.R. 7623); Appropriations report language requests in support of the Food as Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy.
Hospital Inpatient Services Modernization Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts and provider reimbursement; Hospital Inpatient Services Modernization Act (H.R.8260); Telehealth Modernization Act of 2024 (H.R. 7623); Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act (H.R.8260); Telehealth Modernization Act of 2024 (H.R. 7623); Appropriations report language requests in support of the Food as Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy.
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts and provider reimbursement; Hospital Inpatient Services Modernization Act (H.R.8260); Telehealth Modernization Act of 2024 (H.R. 7623); Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act; Appropriations report language requests in support of the Food as Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy.
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, and DIR fees; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act; Appropriations report language requests in support of the Food As Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy; Tax Relief for American Families and Workers Act of 2024 (H.R.7024).
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)
Equality Act (H.R. 15 / S. 5).
Equality Act (H.R. 15/S. 5).
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Drug Origin Transparency Act of 2023 (H.R. 3810); Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees (H.R. 1770); Equitable Community Access to Pharmacist Services Act (H.R. 7053); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; hospital at home acute care.
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; hospital at home acute care.
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, and DIR fees; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; hospital at home acute care; draft legislation related to bona fide servicer fees
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees-H.R. 1770; Equitable Community Access to Pharmacist Services Act-H.R. 7053; VALID Act; Saving Access to Laboratory Services Act (SALSA); Issues related to Medicare provider cuts; Issues related to glucose monitors; Issues related to billing codes.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, and DIR fees; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; hospital at home acute care; draft legislation related to bona fide servicer fees
Drug Origin Transparency Act of 2023 (H.R. 3810); Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees (H.R. 1770); Equitable Community Access to Pharmacist Services Act (H.R. 7053); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; hospital at home acute care.
Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; hospital at home acute care.
Medical and Health Stockpile Accountability Act of 2023
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Medical and Health Stockpile Accountability Act of 2023 (H.R. 3577); Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421): to reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes; fast pass for critical cargo; Issues related to COVID-19 response, Public Health Emergency, provider relief, workforce shortages, federal pharmacy program, pandemic preparedness, and product shortages.
Medical and Health Stockpile Accountability Act of 2023
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Medical and Health Stockpile Accountability Act of 2023 (H.R. 3577); Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421): to reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes; fast pass for critical cargo; Issues related to COVID-19 response, Public Health Emergency, provider relief, workforce shortages, federal pharmacy program, pandemic preparedness, and product shortages.
Drug Origin Transparency Act of 2023
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Drug Origin Transparency Act of 2023 (H.R. 3810); Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees (H.R. 1770); Equitable Community Access to Pharmacist Services Act (H.R. 7053); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; hospital at home acute care.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Medical and Health Stockpile Accountability Act of 2023 (H.R. 3577); Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421): to reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes; fast pass for critical cargo; Issues related to COVID-19 response, Public Health Emergency, provider relief, workforce shortages, federal pharmacy program, pandemic preparedness, and product shortages.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Medical and Health Stockpile Accountability Act of 2023 (H.R. 3577); Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421): to reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes; fast pass for critical cargo; Issues related to COVID-19 response, Public Health Emergency, provider relief, workforce shortages, federal pharmacy program, pandemic preparedness, and product shortages.
Preparing for All Hazards and Pathogens Reauthorization Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421): to reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes; fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); Issues related to COVID-19 response, Public Health Emergency, provider relief, workforce shortages, , pandemic preparedness, and product shortages.
Block, Report, and Suspend Suspicious Shipments Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Pharmaceutical Supply Chain Risk Assessment Act of 2023 (S. 1961); Drug Supply Chain Security Act (DSCSA); Block, Report, and Suspend Suspicious Shipments Act (H.R. 501); Education on supply chain issues, raw material shortages, drug shortages, ports and transportation issues, Buy America, domestic manufacturing, medical device sterilization.
Block, Report, and Suspend Suspicious Shipments Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Drug Supply Chain Security Act (DSCSA); Block, Report, and Suspend Suspicious Shipments Act (H.R. 501); Education on supply chain issues, raw material shortages, drug shortages, ports and transportation issues, Buy America, domestic manufacturing, medical device sterilization; Stop Drug Shortages Act; Supply chain issues and delays related to US border crossings.
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421): to reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes; fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); Issues related to COVID-19 response, Public Health Emergency, provider relief, workforce shortages, , pandemic preparedness, and product shortages.
Orphan Well Grant Flexibility Act of 2024
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees-H.R. 1770; Equitable Community Access to Pharmacist Services Act-H.R. 7053; VALID Act; Saving Access to Laboratory Services Act (SALSA); Issues related to Medicare provider cuts; Issues related to glucose monitors; Issues related to billing codes.
Orphan Well Grant Flexibility Act of 2024
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Drug Origin Transparency Act of 2023 (H.R. 3810); Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees (H.R. 1770); Equitable Community Access to Pharmacist Services Act (H.R. 7053); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; hospital at home acute care.
Pharmaceutical Supply Chain Risk Assessment Act of 2023
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Pharmaceutical Supply Chain Risk Assessment Act of 2023 (S. 1961); Drug Supply Chain Security Act (DSCSA); Block, Report, and Suspend Suspicious Shipments Act (H.R. 501); Education on supply chain issues, raw material shortages, drug shortages, ports and transportation issues, Buy America, domestic manufacturing, medical device sterilization.
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; hospital at home acute care.
Equitable Community Access to Pharmacist Services Act
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, and DIR fees; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; hospital at home acute care; draft legislation related to bona fide servicer fees
Equality Act (H.R. 15 / S. 5).
Equality Act (H.R. 15/S. 5).
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021-H.R. 1199
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)
To provide for a resolution with respect to the unresolved disputes between certain railroads represented by the National Carriers' Conference Committee of the National Railway Labor Conference and certain of their employees.
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
H.J. Res. 100 - To provide for a resolution with respect to the unresolved disputes between certain railroads.
Improving Seniors’ Timely Access to Care Act of 2021
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees; H.R. 7213- Equitable Community Access to Pharmacist Services Act; H.R. 7053- The Hospital Inpatient Services Modernization Act(HR 7053/S 3792); Issues related to the Medical Device User Fee Amendments reauthorization, VALID Act (H.R. 4128/ S. 2209). Saving Access to Laboratory Services Act (SALSA) (HR 8188/S 4449); Improving Seniors Timely Access to Care Act of 2021 (HR 3173/S 3018); Issues related to Medicare provider cuts; Issues related to glucose monitors.
Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees; H.R. 7213- Equitable Community Access to Pharmacist Services Act; H.R. 7053- The Hospital Inpatient Services Modernization Act(HR 7053/S 3792); Issues related to the Medical Device User Fee Amendments reauthorization, VALID Act (H.R. 4128/ S. 2209). Saving Access to Laboratory Services Act (SALSA) (HR 8188/S 4449); Improving Seniors Timely Access to Care Act of 2021 (HR 3173/S 3018); Issues related to Medicare provider cuts; Issues related to glucose monitors.
Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees; H.R. 7213- Equitable Community Access to Pharmacist Services Act; H.R. 7053- The Hospital Inpatient Services Modernization Act; Issues related to the Medical Device User Fee Amendments reauthorization, VALID Act (H.R. 4128/ S. 2209)
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021, H.R. 4479/S. 2609
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: CARDINAL HEALTH INC · Firm: CARDINAL HEALTH, INC.
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021, H.R. 4479/S. 2609
Education on supply chain issues, raw material shortages, and ports and transportation issues including the Ocean Shipping Reform Act of 2022 (S. 3850/H.R. 4996), Buy America, domestic manufacturing, Bipartisan Innovation Act and CHIPS for America Act
Education on supply chain issues, raw material shortages, and ports and transportation issues including the Ocean Shipping Reform Act of 2022 (S. 3850/H.R. 4996), Buy America, domestic manufacturing, Bipartisan Innovation Act and CHIPS for America Act.
Equality Act (H.R. 5/S. 393); Respect for Marriage Act (H.R.8404).
Equality Act (H.R. 5/S. 393); Respect for Marriage Act (H.R.8404)
Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, and reimbursement to home healthcare agencies.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2026 · second_quarter · Q2
Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, and reimbursement to home healthcare agencies. Issues related to tariffs, trade, and U.S. trade policy.
Issues related to tariffs, trade, and U.S. trade policy.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2026 · first_quarter · Q1
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.
Issues related to tariffs, trade, and U.S. trade policy.
Issues related to tariffs, trade, and U.S. trade policy.
Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2025 · fourth_quarter · Q4
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act).
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.
Issues related to tariffs, trade, and U.S. trade policy.
Issues related to tariffs, trade, and U.S. trade policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2025 · second_quarter · 2A
Issues related to tariffs, trade, and U.S. trade policy.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages.
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.
Issues related to tax reform and 2017 Tax Cuts and Jobs Act.
Issues related to tariffs, trade, and U.S. trade policy.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2025 · third_quarter · Q3
Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine and issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025).
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2025 · second_quarter · Q2
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages.
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.
Issues related to tax reform and 2017 Tax Cuts and Jobs Act.
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2025 · first_quarter · Q1
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health, food is medicine, acute hospital care at home waiver; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, pandemic preparedness, and product shortages.
Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation bottlenecks.
Issues related to tax reform and 2017 Tax Cuts and Jobs Act.
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2024 · fourth_quarter · Q4
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts and provider reimbursement; Hospital Inpatient Services Modernization Act (H.R.8260); Telehealth Modernization Act of 2024 (H.R. 7623); Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy
Issues related to tax reform and 2017 Tax Cuts and Jobs Act.
DE+I issues including the Equality Act.
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2024 · third_quarter · Q3
Fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); the National Defense Authorization Act (H.R. 8070); provider reimbursement, workforce shortages, pandemic preparedness, and product shortages.
Issues related to the proposed modifications to the 900MHz ISM Band and Radio Frequency Identification (RFID) technology.
DE+I issues including the Equality Act.
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2024 · second_quarter · Q2
Tax Relief for American Families and Workers Act of 2024 (H.R.7024); research and development tax credit.
Drug Supply Chain Security Act (DSCSA); Education on supply chain issues, raw material shortages, drug shortages, ports and transportation issues, Buy America, domestic manufacturing, medical device sterilization; Stop Drug Shortages Act; Supply chain issues and delays related to US border crossings; Issues related to the medical supply chain and transportation bottlenecks.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act; Appropriations report language requests in support of the Food as Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy.
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2024 · first_quarter · Q1
Drug Supply Chain Security Act (DSCSA); Education on supply chain issues, raw material shortages, drug shortages, ports and transportation issues, Buy America, domestic manufacturing, medical device sterilization; Stop Drug Shortages Act; Supply chain issues and delays related to US border crossings; Issues related to the medical supply chain and transportation bottlenecks.
DE+I issues including the Equality Act
Exclusion of health care related products in section 301 tariffs
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2023 · fourth_quarter · Q4
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)
Drug Supply Chain Security Act (DSCSA); Education on supply chain issues, raw material shortages, drug shortages, ports and transportation issues, Buy America, domestic manufacturing, medical device sterilization; Stop Drug Shortages Act; Supply chain issues and delays related to US border crossings; Issues related to the medical supply chain and transportation bottlenecks.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, and DIR fees; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; hospital at home acute care; draft legislation related to bona fide servicer fees
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2023 · third_quarter · Q3
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)
Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; hospital at home acute care.
Equality Act (H.R. 15 / S. 5).
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2023 · second_quarter · Q2
Medical and Health Stockpile Accountability Act of 2023 (H.R. 3577); Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421): to reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes; fast pass for critical cargo; Issues related to COVID-19 response, Public Health Emergency, provider relief, workforce shortages, federal pharmacy program, pandemic preparedness, and product shortages.
Exclusion of health care related products in section 301 tariffs
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2023 · first_quarter · Q1
Issues related to COVID-19 response, Public Health Emergency, provider relief, workforce shortages, federal pharmacy program, pandemic preparedness, and product shortages.
Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees-H.R. 1770; Equitable Community Access to Pharmacist Services Act-H.R. 7053; VALID Act; Saving Access to Laboratory Services Act (SALSA); Issues related to Medicare provider cuts; Issues related to glucose monitors; Issues related to billing codes.
Equality Act
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2022 · fourth_quarter · Q4
Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees; H.R. 7213- Equitable Community Access to Pharmacist Services Act; H.R. 7053- The Hospital Inpatient Services Modernization Act(HR 7053/S 3792); Issues related to the Medical Device User Fee Amendments reauthorization, VALID Act (H.R. 4128/ S. 2209). Saving Access to Laboratory Services Act (SALSA) (HR 8188/S 4449); Improving Seniors Timely Access to Care Act of 2021 (HR 3173/S 3018); Issues related to Medicare provider cuts; Issues related to glucose monitors.
Education on supply chain issues, raw material shortages, and ports and transportation issues including the Ocean Shipping Reform Act of 2022 (S. 3850/H.R. 4996), Buy America, domestic manufacturing, Bipartisan Innovation Act and CHIPS for America Act.
CARDINAL HEALTH INC via CARDINAL HEALTH, INC.
2022 · third_quarter · Q3
Appropriations report language requests in support of a Medical Distribution Supply Chain Task Force, IT Interoperability for the Strategic National Stockpile, and Reimbursement for Vaccine Network Administrators
Equality Act (H.R. 5/S. 393); Respect for Marriage Act (H.R.8404)
Exclusion of health care related products in section 301 tariffs.
Issues related to tariffs, trade, and U.S. trade policy.
Issues related to tariffs, trade, and U.S. trade policy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Issues related to tariffs, trade, and U.S. trade policy.
Issues related to tariffs, trade, and U.S. trade policy.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Issues related to tariffs, trade, and U.S. trade policy.
Issues related to tariffs, trade, and U.S. trade policy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
Drug Supply Chain Security Act (DSCSA); Education on supply chain issues, raw material shortages, drug shortages, ports and transportation issues, domestic manufacturing, medical device sterilization; Stop Drug Shortages Act; Drug Shortage Prevention and Mitigation Act; Supply chain issues and delays related to US borders and ports; Issues related to the medical supply chain and transportation bottlenecks.
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)
Issues related to tariffs and US trade policy
Fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); the National Defense Authorization Act (H.R. 8070); provider reimbursement, workforce shortages, pandemic preparedness, and product shortages.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to tax reform and 2017 Tax Cuts and Jobs Act.
Drug Supply Chain Security Act (DSCSA); Education on supply chain issues, raw material shortages, drug shortages, ports and transportation issues, domestic manufacturing, medical device sterilization; Stop Drug Shortages Act; Drug Shortage Prevention and Mitigation Act; Supply chain issues and delays related to US borders and ports; Issues related to the medical supply chain and transportation bottlenecks.
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act (H.R.8260); Telehealth Modernization Act of 2024 (H.R. 7623); Appropriations report language requests in support of the Food as Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy.
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
DE+I issues including the Equality Act.
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421); fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); provider reimbursement, workforce shortages, pandemic preparedness, and product shortages.
Exclusion of health care related products in section 301 tariffs.
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)
Tax Relief for American Families and Workers Act of 2024 (H.R.7024)
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421): to reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes; fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); , provider relief, workforce shortages, pandemic preparedness, and product shortages
Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, and DIR fees; Equitable Community Access to Pharmacist Services Act (H.R. 1770 / S. 2477); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; Hospital Inpatient Services Modernization Act; Appropriations report language requests in support of the Food As Medicine initiative and examining drug shortages policies; Cybersecurity in healthcare; Issues related to cybersecurity attacks and the effects on pharmacy; Tax Relief for American Families and Workers Act of 2024 (H.R.7024).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421): to reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes; fast pass for critical cargo (H.R. 6140 Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation Act); Issues related to COVID-19 response, Public Health Emergency, provider relief, workforce shortages, , pandemic preparedness, and product shortages.
Exclusion of health care related products in section 301 tariffs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Drug Supply Chain Security Act (DSCSA); Block, Report, and Suspend Suspicious Shipments Act (H.R. 501); Education on supply chain issues, raw material shortages, drug shortages, ports and transportation issues, Buy America, domestic manufacturing, medical device sterilization; Stop Drug Shortages Act; Supply chain issues and delays related to US border crossings.
Medical and Health Stockpile Accountability Act of 2023 (H.R. 3577); Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization (H.R. 4421): to reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes; fast pass for critical cargo; Issues related to COVID-19 response, Public Health Emergency, provider relief, workforce shortages, federal pharmacy program, pandemic preparedness, and product shortages.
Exclusion of health care related products in section 301 tariffs
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Drug Origin Transparency Act of 2023 (H.R. 3810); Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees (H.R. 1770); Equitable Community Access to Pharmacist Services Act (H.R. 7053); VALID Act (H.R. 2369); Issues related to Medicare provider cuts; hospital at home acute care.
Pharmaceutical Supply Chain Risk Assessment Act of 2023 (S. 1961); Drug Supply Chain Security Act (DSCSA); Block, Report, and Suspend Suspicious Shipments Act (H.R. 501); Education on supply chain issues, raw material shortages, drug shortages, ports and transportation issues, Buy America, domestic manufacturing, medical device sterilization.
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 (H.R. 1199)
Equality Act (H.R. 15/S. 5).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Education on supply chain issues, raw material shortages, ports and transportation issues, Buy America, domestic manufacturing, Bipartisan Innovation Act and CHIPS for America Act.
Exclusion of health care related products in section 301 tariffs
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021-H.R. 1199
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Issues related to COVID-19 response, provider relief, workforce shortages, federal pharmacy program, pandemic preparedness, and product shortages; S.3799 - PREVENT Pandemics Act.
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021, H.R. 4479/S. 2609
Appropriations report language requests in support of a Medical Distribution Supply Chain Task Force, IT Interoperability for the Strategic National Stockpile, and Reimbursement for Vaccine Network Administrators.
H.J. Res. 100 - To provide for a resolution with respect to the unresolved disputes between certain railroads.
Equality Act (H.R. 5/S. 393); Respect for Marriage Act (H.R.8404).
Exclusion of health care related products in section 301 tariffs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Issues related to drug pricing, pharmacies, provider status, biosimilars, and DIR fees; H.R. 7213- Equitable Community Access to Pharmacist Services Act; H.R. 7053- The Hospital Inpatient Services Modernization Act; Issues related to the Medical Device User Fee Amendments reauthorization, VALID Act (H.R. 4128/ S. 2209)
Issues related to COVID-19 response, provider relief, workforce shortages, federal pharmacy program, pandemic preparedness, and product shortages
Nuclear shortage issues and Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021, H.R. 4479/S. 2609
Education on supply chain issues, raw material shortages, and ports and transportation issues including the Ocean Shipping Reform Act of 2022 (S. 3850/H.R. 4996), Buy America, domestic manufacturing, Bipartisan Innovation Act and CHIPS for America Act
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office